Search

Your search keyword '"Rauch, Christiane"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Rauch, Christiane" Remove constraint Author: "Rauch, Christiane" Search Limiters Full Text Remove constraint Search Limiters: Full Text
20 results on '"Rauch, Christiane"'

Search Results

1. Serious Games in Academic Education – A Multi-dimensional Sustainability Analysis of Additive Versus Conventional Manufacturing Technologies in a Fictitious Enterprise Project

4. Additional file 1: of Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

5. Additional file 3: of Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

6. Additional file 2: of Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

7. Case Reports1. A Late Presentation of Loeys-Dietz Syndrome: Beware of TGFβ Receptor Mutations in Benign Joint Hypermobility

8. Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

10. Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis:24-month results from an international, prospective, real-world study

12. Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study

13. Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

14. Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

16. 100. Predictors of Retention with Abatacept in Patients who Have Failed One or More Biologic Agents: Results from the International, Real-World Action Study

17. Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study

18. Case Reports1. A Late Presentation of Loeys-Dietz Syndrome: Beware of TGFβ Receptor Mutations in Benign Joint Hypermobility

19. Phenotype and genotype of 87 patients with Mowat-Wilson syndrome and recommendations for care

20. Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.

Catalog

Books, media, physical & digital resources